v3.25.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Deferred Shares
Additional Paid-in Capital
Accumulated deficit
Accumulated other comprehensive (loss) income
Beginning balance (in shares) at Dec. 31, 2023   49,725,649 5,793,501      
Beginning balance at Dec. 31, 2023 $ 368,843 $ 134 $ 1 $ 1,149,643 $ (744,674) $ (36,261)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (24,436)       (24,436)  
Other comprehensive income 897         897
Exercise of share options (in shares)   280,436        
Exercise of share options 5,213 $ 1   5,212    
Share-based compensation expense 9,017     9,017    
Ending balance (in shares) at Mar. 31, 2024   50,006,085 5,793,501      
Ending balance at Mar. 31, 2024 $ 359,534 $ 135 $ 1 1,163,872 (769,110) (35,364)
Beginning balance (in shares) at Dec. 31, 2024 50,064,860 50,064,860 5,793,501      
Beginning balance at Dec. 31, 2024 $ 360,716 $ 135 $ 1 1,190,104 (795,761) (33,763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 5,023       5,023  
Other comprehensive income $ 673         673
Exercise of share options (in shares) 119,749 119,749        
Exercise of share options $ 2,551     2,551    
Share-based compensation expense $ 9,516     9,516    
Ending balance (in shares) at Mar. 31, 2025 50,184,609 50,184,609 5,793,501      
Ending balance at Mar. 31, 2025 $ 378,479 $ 135 $ 1 $ 1,202,171 $ (790,738) $ (33,090)